ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

April 15, 1988

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

October 26, 1990

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011